Consensus Geron Corporation

Equities

GERN

US3741631036

Market Closed - Nasdaq 16:00:00 2024-06-21 EDT 5-day change 1st Jan Change
4.63 USD +3.81% Intraday chart for Geron Corporation -4.93% +119.43%

Evolution of the average Target Price on Geron Corporation

Price target over the last 5 years

History of analyst recommendation changes

0b96558edd8fc14c6.kLP-4foE2korqGAs-vLIobhGE-IKWQ5dltKFIds31dk.p_m0i7Z9k3xY5QUanoCBzJVwYpFgGkNv2ZbWd-1ev7D67JKZuTy2e3PxNQ~153c6164dff8d47a9bf2cd7e4661f932
Geron Insider Sold Shares Worth $1,334,129, According to a Recent SEC Filing MT
Barclays Initiates Geron at Overweight Rating With $9 Price Target MT
Stifel Nicolaus Adjusts Geron Price Target to $7 From $6, Maintains Buy Rating MT
Wedbush Raises Geron's Price Target to $8 From $7, Outperform Rating Maintained MT
Needham Adjusts Geron Price Target to $6 From $5, Maintains Buy Rating MT
Wedbush Adjusts Geron's Price Target to $7 From $6, Keeps Outperform Rating MT
Baird Downgrades Geron to Neutral From Outperform, Price Target at $4.50 MT
TD Cowen Initiates Geron With Buy Rating, $10 Price Target MT
Needham Adjusts Geron's Price Target to $5 From $4, Maintains Buy Rating MT
Goldman Sachs Adjusts Price Target on Geron to $5 From $4, Keeps Buy Rating MT
Goldman Sachs Upgrades Geron to Buy From Neutral, Price Target is $4 MT
Goldman Sachs Initiates Geron at Neutral With $3 Price Target MT
Needham Adjusts Price Target on Geron to $4 From $3, Maintains Buy Rating MT
B. Riley Lifts Geron's PT to $5 From $4, Keeps Buy Rating After Positive Topline Results From Phase III Trial of Imetelstat MT
Wedbush Lifts Geron's Price Target to $6 From $5, Keeps Outperform Rating MT
Wedbush Starts Geron at Outperform With $5 Price Target MT
Needham & Co Adjusts Geron Price Target to $3 From $2, Maintains Buy Rating MT
B. Riley Resumes Geron at Buy with $4 Price Target, Says Thesis Hinges on Potential Success of Imetelstat MT
Needham Trims Geron's Price Target to $2 From $3, Buy Rating Kept MT
Baird Starts Geron at Outperform With $4 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
4.65 USD
Average target price
6.938 USD
Spread / Average Target
+49.19%
High Price Target
10 USD
Spread / Highest target
+115.05%
Low Price Target
4.5 USD
Spread / Lowest Target
-3.23%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Geron Corporation

Barclays
Stifel Nicolaus
Wedbush
Needham & Co.
Baird
TD Cowen
Goldman Sachs
B. Riley
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
  1. Stock Market
  2. Equities
  3. GERN Stock
  4. Consensus Geron Corporation